Index tracked: MSCI Europe Enhanced Value TRN Index (EUR)
TER
0.15%+ trans. 0.05%
Fund size
337 m EUR
Tracking difference
+0.39%3-year avg
🇮🇹 tax rate
—white list not published
Replication
Physical
Income
Accumulating
Launch 26 Mar 2010 · costs from the KID as of 2 Sept 2026 · 154 securities held · 8 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 4 Aug 2026
The fund is passively managed.
INVESTMENT OBJECTIVE:
The aim is for your investment to reflect the performance of the MSCI Europe Enhanced Value TRN index (index) which is designed to reflect the performance of the shares of certain companies from European markets.
DESCRIPTION OF INDEX:
The shares are chosen on the basis that they exhibit higher value characteristics relative to their peers within the corresponding GICS® sector. When selecting which shares to choose, a number of factors are considered, including the market value of the company…
Performance since series start (in euro) — base 100
26 Mar 2010 → 8 Sept 2026 · dividends reinvested where declared by the issuer
High 375 (4 Aug 2026) · low 82 (24 Nov 2011) · last 370. Past performance is not indicative of future results.
The live sheet, always up to date rebalix.com/en/etf/LU0486851024 Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.